These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 29249493

  • 1. Exendin-4 improves cardiovascular function and survival in flow-induced pulmonary hypertension.
    Roan JN, Hsu CH, Fang SY, Tsai HW, Luo CY, Huang CC, Lam CF.
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1661-1669.e4. PubMed ID: 29249493
    [Abstract] [Full Text] [Related]

  • 2. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS, Kim DH, Lee YJ, Lee SE, Kang WJ, Chang HJ, Shin JS.
    Respir Res; 2014 Nov 25; 15():148. PubMed ID: 25420924
    [Abstract] [Full Text] [Related]

  • 3. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A, Trappiel M, Berghausen EM, Ten Freyhaus H, Wellnhofer E, Odenthal M, Blaschke F, Er F, Gassanov N, Rosenkranz S, Baldus S, Kappert K, Caglayan E.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr 25; 389(4):369-79. PubMed ID: 26742933
    [Abstract] [Full Text] [Related]

  • 4. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X, Yang Y, Yang D, Tong G, Lv S, Lin X, Chen C, Dong W.
    J Vasc Surg; 2016 Nov 25; 64(5):1468-1477. PubMed ID: 26527422
    [Abstract] [Full Text] [Related]

  • 5. Chrysin Alleviates Monocrotaline-Induced Pulmonary Hypertension in Rats Through Regulation of Intracellular Calcium Homeostasis in Pulmonary Arterial Smooth Muscle Cells.
    Dong F, Zhang J, Chen X, Zhang S, Zhu L, Peng Y, Guo Z.
    J Cardiovasc Pharmacol; 2020 Jun 25; 75(6):596-602. PubMed ID: 32168153
    [Abstract] [Full Text] [Related]

  • 6. Functional Improvement and Regression of Medial Hypertrophy in the Remodeled Pulmonary Artery after Correction of Systemic Left-to-Right Shunt.
    Hsu CH, Roan JN, Chen JH, Lam CF.
    Sci Rep; 2016 Nov 25; 6():37684. PubMed ID: 27886226
    [Abstract] [Full Text] [Related]

  • 7. Effect of a surgical aortocaval fistula on monocrotaline-induced pulmonary hypertension.
    Nishimura T, Faul JL, Berry GJ, Kao PN, Pearl RG.
    Crit Care Med; 2003 Apr 25; 31(4):1213-8. PubMed ID: 12682495
    [Abstract] [Full Text] [Related]

  • 8. Ventricular and pulmonary vascular remodeling induced by pulmonary overflow in a chronic model of pretricuspid shunt.
    Linardi D, Rungatscher A, Morjan M, Marino P, Luciani GB, Mazzucco A, Faggian G.
    J Thorac Cardiovasc Surg; 2014 Dec 25; 148(6):2609-17. PubMed ID: 24908349
    [Abstract] [Full Text] [Related]

  • 9. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
    Rocchetti M, Sala L, Rizzetto R, Staszewsky LI, Alemanni M, Zambelli V, Russo I, Barile L, Cornaghi L, Altomare C, Ronchi C, Mostacciuolo G, Lucchetti J, Gobbi M, Latini R, Zaza A.
    Cardiovasc Res; 2014 Oct 01; 104(1):37-48. PubMed ID: 25139747
    [Abstract] [Full Text] [Related]

  • 10. Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats.
    Leong ZP, Hikasa Y.
    Vascul Pharmacol; 2018 Nov 01; 110():31-41. PubMed ID: 30071297
    [Abstract] [Full Text] [Related]

  • 11. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
    Leong ZP, Okida A, Higuchi M, Yamano Y, Hikasa Y.
    Vascul Pharmacol; 2018 Jan 01; 100():41-50. PubMed ID: 29100963
    [Abstract] [Full Text] [Related]

  • 12. Rosuvastatin, sildenafil and their combination in monocrotaline-induced pulmonary hypertension in rat.
    Jasińska-Stroschein M, Owczarek J, Wesołowska A, Orszulak-Michalak D.
    Acta Pharm; 2014 Sep 01; 64(3):345-53. PubMed ID: 25296680
    [Abstract] [Full Text] [Related]

  • 13. Endothelin A receptor blockade improves regression of flow-induced pulmonary vasculopathy in piglets.
    Mercier O, Sage E, Izziki M, Humbert M, Dartevelle P, Eddahibi S, Fadel E.
    J Thorac Cardiovasc Surg; 2010 Sep 01; 140(3):677-83. PubMed ID: 20723731
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
    Adão R, Mendes-Ferreira P, Santos-Ribeiro D, Maia-Rocha C, Pimentel LD, Monteiro-Pinto C, Mulvaney EP, Reid HM, Kinsella BT, Potus F, Breuils-Bonnet S, Rademaker MT, Provencher S, Bonnet S, Leite-Moreira AF, Brás-Silva C.
    Cardiovasc Res; 2018 Jul 01; 114(8):1165-1177. PubMed ID: 29584808
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transplantation of viable mitochondria improves right ventricular performance and pulmonary artery remodeling in rats with pulmonary arterial hypertension.
    Hsu CH, Roan JN, Fang SY, Chiu MH, Cheng TT, Huang CC, Lin MW, Lam CF.
    J Thorac Cardiovasc Surg; 2022 May 01; 163(5):e361-e373. PubMed ID: 32948302
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. L-arginine impacts pulmonary vascular structure in rats with an aortocaval shunt.
    Bing W, Junbao D, Jianguang Q, Jian L, Chaoshu T.
    J Surg Res; 2002 Nov 01; 108(1):20-31. PubMed ID: 12443711
    [Abstract] [Full Text] [Related]

  • 20. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
    Li XL, Guan RJ, Li JJ.
    J Cardiovasc Pharmacol; 2012 Aug 01; 60(2):219-26. PubMed ID: 22592772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.